Invitrogen™ Kit ELISA IL-1 beta de souris

Réf. : BL-RE-171992Réf. fabricant : BMS6002-2 96 Tests
714,00 € HT

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Numéro d’adhésion
P10749
Plage de dosage
7.8 to 500
Sensibilité du dosage
1.2 pg/mL
Conjugué
HRP
Type de produit
ELISA
Marque
Invitrogen

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol. Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals. Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta. IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is secreted alongside caspase-1 via an alternate and incompletely understood mechanism. Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions. IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha. IL-1 beta activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition. IL-1 beta play an important role in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses to infection and injury. Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions IL-1 beta neutralizing antibodies potential therapeutic value.

Sensibilité

Sensibilité du dosage : 1,2 pg/mL.

Plage de mesure

Plage de dosage : 7,8 à 500.

Durée du dosage

Durée totale du dosage : 3 h 10 min.

Reproductibilité

Coefficient de variation intra-dosage 5,1%, inter-dosage 5,7%.

Échantillons

Type d’échantillon : Serum (volume 50 µL).

Caractéristiques techniques

Général
MarqueInvitrogen
Réf. fournisseur (Fisher Scientific)18061673
Caractéristiques
Numéro d’adhésionP10749
Plage de dosage7.8 to 500
Sensibilité du dosage1.2 pg/mL
ConjuguéHRP
Type de produitELISA
Type d’échantillonSerum
À utiliser avec (équipement)Colorimetric Microplate Reader
Identification génétique (Entrez)16176
Symbole de gène(s)IL1B
Coefficient de variation inter-dosage5.7%
Coefficient de variation intra-dosage5.1%
Contenus des kitsPre-coated 96 well plate, Standard, Sample Diluent, Assay Buffer concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers
Marqueur ou colorantHRP
Quantité96 Tests
État réglementaireRUO
CibleMouse
Heure du test1 hr 20 min
Caractéristiques physiques
Volume d’échantillon50 µL
Stockage et expédition
Conditions de stockage2°C to 8°C
Durée totale du dosage3 hr 10 min

Origine et douane

Réf. fabricantBMS6002-2
Pays d’origineAutriche
Code douanier (SH)3822 11 00 00
Une question, une configuration particulière ?
Contactez-nous pour un devis.